**The full Subcommittee hearing is available HERE**

**Kuster’s full remarks are available HERE**

Washington, D.C. — Today, Rep. Annie Kuster (NH-02), a member of the Energy and Commerce Health Subcommittee, participated in a hearing entitled, “The Future of Medicine: Legislation to Encourage Innovation and Improve Oversight." During the hearing, Kuster urged Congress to take action to make lower-cost drugs available to Granite Staters. She also spoke about legislation she introduced, the Increasing Transparency in Generic Drug Applications Act, which would allow the FDA to provide feedback on proposed drug formulations to generic drug applicants and increase the availability of more affordable medications.

“Medication is only as good as it is affordable — I hear consistently from Granite Staters about how their prescriptions are simply too expensive, and how they have to make difficult decisions around paying for rent or their mortgage and taking their medications,” said Rep. Kuster. “That is why I recently introduced the Increasing Transparency in Generic Drug Applications Act, legislation to make lower-cost drugs available for more Americans. I look forward to getting this done for patients in the Granite State and across the country.”

Kuster’s Increasing Transparency in Generic Drug Applications Act would address a major barrier to generic drug approval and expedite patient access to affordable medicines by clarifying that FDA can provide generic drug applicants with improved directional guidance on their proposed formulation for complex generic drugs.

###